Perng D W, Chen C H, Lee Y C, Perng R P
Chest Department, Veterans General Hospital-Taipei, Taiwan, R.O.C.
Zhonghua Yi Xue Za Zhi (Taipei). 1996 May;57(5):343-7.
Cutaneous metastases in primary lung cancer rarely occurs in comparison with other organ involvement. Because of the absence of any uniform or pathognomic feature, they are often mistaken as a variety of benign lesions so that the outcome is extremely different. In this study, sixty-three cases of lung cancer with cutaneous metastases were retrospectively analyzed to determine the clinical pictures and length of survival.
Retrospective analyses were performed for 5539 cases of proven lung cancer collected at the Cancer Treatment Center in Veterans General Hospital-Taipei during the period from January 1984 to May 1994. Seventy-two cases were documented cutaneous metastases. Nine of them were excluded due to inadequate medical records on clinical course.
Group A included the majority (48/63, 76.2%) of patients who had primary lung cancer with subsequent cutaneous metastases. The other 15 patients with cutaneous metastases as the initial presentations were classified as group B. (15/63, 23.8%). There were four major clinical presentations; solitary nodules, cluster of nodules, erythematous papule and bulging mass. Solitary nodule was the most frequent pattern (41/63 65.1%), ranging in size from 0.5 x 0.5 cm to 25 x 15 cm in surface area. The chest wall and abdominal wall were the regions most likely to develop cutaneous metastases. Metastatic lesions were occasionally found over the scrotum, lip and perianal region. Adenocarcinoma was the predominant cell type of cutaneous spread (25/63, 39.7%). The survival after diagnosis of cutaneous metastasis ranged from 3 weeks to 14 months, without significant difference between two groups of patients. Twenty-two patients (35%) survived no more than one month. The median survival was 3 months.
Cutaneous metastasis, as observed in our study, is an ominous sign indicating a poor prognosis with imminent death. Physicians should be alert to its characteristics and prognostic significance.
与其他器官受累相比,原发性肺癌的皮肤转移很少见。由于缺乏任何统一或特征性表现,它们常被误诊为各种良性病变,导致治疗结果截然不同。本研究对63例发生皮肤转移的肺癌患者进行回顾性分析,以确定其临床表现和生存时间。
对1984年1月至1994年5月期间台北荣民总医院癌症治疗中心收集的5539例确诊肺癌病例进行回顾性分析。有72例记录有皮肤转移。其中9例因临床病程记录不完整而被排除。
A组包括大多数(48/63,76.2%)原发性肺癌继发皮肤转移的患者。另外15例以皮肤转移为首发表现的患者被归为B组(15/63,23.8%)。有四种主要临床表现:孤立结节、结节簇、红斑丘疹和隆起肿块。孤立结节是最常见的类型(41/63,65.1%),表面积大小从0.5×0.5厘米至25×15厘米不等。胸壁和腹壁是最易发生皮肤转移的部位。转移灶偶尔见于阴囊、唇部和肛周区域。腺癌是皮肤转移的主要细胞类型(25/63,39.7%)。皮肤转移诊断后的生存期为3周至14个月,两组患者之间无显著差异。22例患者(35%)存活不超过1个月。中位生存期为3个月。
正如我们研究中所观察到的,皮肤转移是一个不祥之兆,表明预后不良且即将死亡。医生应警惕其特征和预后意义。